Navigation Links
InVitria Headlines Sponsorship of WilBio's Waterside Conference

Supplier of high performance cell culture media components will reveal significant advantages of its products at the 14th International Meeting of The Waterside Conference, April 20-22 in San Francisco.

Fort Collins, CO (PRWEB) April 9, 2009 -- InVitria's line of high performance cell culture media components used for mammalian cell culture will be showcased at the upcoming Williamsburg BioProcessing Foundation The Waterside Conference on April 20-22, 2009, in South San Francisco.

Regarded as one of the leading events addressing scale-up and production issues facing the bioprocessing industry, the 2009 Waterside Conference comes at an opportune time for InVitria to share its product advantages with commercial biomanufacturers.

InVitria's Cellastim (recombinant human serum albumin) and Lacromin (recombinant Lactoferrin) have been used by large-scale commercial manufacturers to significantly improve CHO cell growth and productivity. Cellastim also increases hybridoma cell growth and monoclonal antibody production.

InVitria's Director of Cell Culture, Dr. Steve Pettit, will present two posters at the conference revealing the optimization benefits of InVitria's Cellastim in CHO and hybridoma cell lines. "Recent research from our own work and that of customers shows substantial improvements in the speed of cell line development and seed-train expansion using InVitria's recombinant product," said Dr. Pettit. "This is especially important for our customers who want to eliminate animal-derived components and also expedite their product development process," he continued.

"We are glad to partner with WilBio as a sponsor for this industry-leading event," commented Scott Deeter, InVitria President and CEO. "At The Waterside Conference, we invite existing and new customers to visit our booth to learn how InVitria can help you optimize productivity, reduce product development time and achieve your regulatory objectives."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research and diagnostics.

For more information about InVitria's products, please contact us by e-mail or phone.

E-mail: info(at)InVitria(dot)com
Phone: 1-800-916-8311


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Announces Launch of Recombinant Albumin for Diagnostics
2. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
3. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
4. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
5. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
6. InVitria to Present at WilBio's International Cell Engineering Meeting
7. Oprah Show Expert and RealAge Cofounder Headlines ePharma Talk
8. Good News in Africa: Beyond the headlines
9. Fitness Model / Entrepreneur Targets Childhood Obesity and Makes Headlines Nationwide With New Franchise Offering
10. NHS Choices Launches Medical News Guide to What Lies Behind the Headlines
11. THE Aesthetic Show Attracts Record Sponsorship
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... that they are handling security in light of the recent terrorist attacks in Paris, ... attempt to stop an attack from reaching U.S. soil. Especially around special events that ...
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
Breaking Medicine Technology: